Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swiss (SMI) Chemicals Industry Analysis

UpdatedJun 26, 2026
DataAggregated Company Financials
Companies5
  • 7D3.3%
  • 3M23.9%
  • 1Y-11.0%
  • YTD10.5%

In the last week, the Chemicals industry is up 3.3%, with Givaudan up 6.2%. In the past year, the industry is down 11%. As for the next few years, earnings are expected to grow by 8.3% per annum.

Industry Valuation and Performance

Has the Swiss Chemicals Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 26 Jun 2026CHF 77.5bCHF 24.9bCHF 2.4b29.2x31.7x3.1x
Sun, 24 May 2026CHF 68.9bCHF 24.9bCHF 2.4b24.8x28.2x2.8x
Tue, 21 Apr 2026CHF 69.7bCHF 24.9bCHF 2.4b25x28.5x2.8x
Thu, 19 Mar 2026CHF 64.4bCHF 24.9bCHF 2.4b23.9x26.3x2.6x
Sat, 14 Feb 2026CHF 71.3bCHF 25.3bCHF 2.7b25.4x25.9x2.8x
Mon, 12 Jan 2026CHF 71.7bCHF 25.4bCHF 2.8b24.5x25.9x2.8x
Wed, 10 Dec 2025CHF 70.8bCHF 25.4bCHF 2.8b24.1x25.6x2.8x
Fri, 07 Nov 2025CHF 69.9bCHF 25.4bCHF 2.8b23.8x25.3x2.7x
Sun, 05 Oct 2025CHF 74.8bCHF 25.6bCHF 2.8b25.5x26.7x2.9x
Tue, 02 Sep 2025CHF 78.1bCHF 25.6bCHF 2.8b26.5x27.9x3x
Thu, 31 Jul 2025CHF 81.5bCHF 26.0bCHF 3.0b27.2x27x3.1x
Sat, 28 Jun 2025CHF 88.3bCHF 25.8bCHF 3.0b29.5x29.3x3.4x
Mon, 26 May 2025CHF 90.4bCHF 25.8bCHF 3.0b29.7x30x3.5x
Wed, 23 Apr 2025CHF 82.3bCHF 25.8bCHF 3.0b27x27.3x3.2x
Fri, 21 Mar 2025CHF 92.4bCHF 25.8bCHF 3.0b30.5x30.6x3.6x
Sun, 16 Feb 2025CHF 95.3bCHF 25.8bCHF 2.9b32.9x32.6x3.7x
Tue, 14 Jan 2025CHF 88.5bCHF 25.5bCHF 2.9b31.1x30.9x3.5x
Thu, 12 Dec 2024CHF 92.9bCHF 25.5bCHF 2.9b32.1x32.5x3.6x
Sat, 09 Nov 2024CHF 93.6bCHF 25.5bCHF 2.9b32.9x32.8x3.7x
Mon, 07 Oct 2024CHF 103.9bCHF 25.6bCHF 2.8b34.9x36.5x4.1x
Wed, 04 Sep 2024CHF 105.0bCHF 25.6bCHF 2.8b35.8x36.9x4.1x
Fri, 02 Aug 2024CHF 104.2bCHF 25.7bCHF 2.8b36.4x36.7x4.1x
Sun, 30 Jun 2024CHF 102.7bCHF 25.2bCHF 2.6b37.6x39.7x4.1x
Tue, 28 May 2024CHF 107.8bCHF 25.2bCHF 2.6b38.6x41.7x4.3x
Thu, 25 Apr 2024CHF 99.9bCHF 25.2bCHF 2.5b38x40.2x4x
Sat, 23 Mar 2024CHF 101.7bCHF 25.2bCHF 2.5b40.8x40.7x4x
Mon, 19 Feb 2024CHF 93.2bCHF 25.8bCHF 2.2b37.9x41.9x3.6x
Wed, 17 Jan 2024CHF 91.9bCHF 26.1bCHF 2.3b35.5x40.6x3.5x
Fri, 15 Dec 2023CHF 99.3bCHF 26.1bCHF 2.3b37.1x43.9x3.8x
Sun, 12 Nov 2023CHF 87.3bCHF 26.1bCHF 2.3b33.3x38.5x3.3x
Tue, 10 Oct 2023CHF 84.7bCHF 25.7bCHF 2.2b31.5x38x3.3x
Thu, 07 Sep 2023CHF 88.7bCHF 25.7bCHF 2.2b33.2x39.8x3.4x
Sat, 05 Aug 2023CHF 94.4bCHF 25.7bCHF 2.5b36.7x37.5x3.7x
Mon, 03 Jul 2023CHF 90.6bCHF 26.1bCHF 2.5b33.9x36.7x3.5x
Price to Earnings Ratio

36.7x


Total Market Cap: CHF 90.6bTotal Earnings: CHF 2.5bTotal Revenue: CHF 26.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Swiss Chemicals Industry Price to Earnings3Y Average 33.2x202420252026
Current Industry PE
  • Investors are relatively neutral on the Swiss Chemicals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 33.2x.
  • The industry is trading close to its 3-year average PS ratio of 3.4x.
Past Earnings Growth
  • Both revenue and earnings for companies in the Chemicals industry have remained mostly flat over the last three years.
  • This means that sales and the cost of doing business have remained relatively consistent over this period and subsequently, so have profits.

Industry Trends

Which industries have driven the changes within the Swiss Materials industry?

CH Market2.77%
Materials1.40%
Chemicals3.32%
Specialty Chemicals3.32%
Industry PE
  • Investors are most optimistic about the Specialty Chemicals industry, which is trading close to its 3-year average PE ratio of 33.2x.
    • Analysts are expecting annual earnings growth of 8.3%, which is higher than its past year's earnings decline of 1.7% per year.
  • Investors are most pessimistic about the Specialty Chemicals industry, which is trading close to its 3-year average of 33.2x.
Forecasted Growth
  • Analysts are most optimistic on the Specialty Chemicals industry, expecting annual earnings growth of 8.3% over the next 5 years.
  • This is better than its past earnings decline of 1.7% per year.
  • In contrast, the Specialty Chemicals industry is expected to see its earnings grow by 8.3% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
GIVN GivaudanCHF 3.39k6.2%
+CHF 1.8b		-12.6%PE29.2x
SIKA SikaCHF 168.001.5%
+CHF 401.1m		-22.0%PE25.8x
EMSN EMS-CHEMIE HOLDINGCHF 711.501.6%
+CHF 257.3m		20.3%PE35.7x
GURN Gurit HoldingCHF 38.4011.3%
+CHF 18.2m		119.4%PS0.6x

Latest News

GIVN
CHF 3,392.00
Givaudan
7D
6.2%
1Y
-12.6%
Narrative Update • Jun 25

GIVN: Pricing Power And AI Beauty Push Will Shape Future Margin Resilience

Givaudan's analyst fair value estimate has been adjusted modestly higher to CHF 3,468 from CHF 3,415, reflecting analysts' updated assumptions for slightly stronger revenue growth, a similar discount rate, a broadly unchanged profit margin profile, and a small increase in expected future P/E multiples, alongside a recent series of price target revisions across the Street that now cluster in the CHF 2,900 to CHF 3,500 range. Analyst Commentary Recent research on Givaudan points to a mixed but generally constructive view, with several firms adjusting price targets in a relatively tight CHF 2,900 to CHF 3,500 band and a blend of rating upgrades and downgrades.
SIKA
CHF 168.00
Sika
7D
1.5%
1Y
-22.0%
Narrative Update • Jun 24

SIKA: New Facilities And Mixed Ratings Set Up Measured Repricing Potential

The analyst price target for Sika has been adjusted slightly higher to CHF 180.69. Analysts point to refined assumptions on margins, a modestly higher future P/E of about 22.73, and recent target moves, such as the JPMorgan upgrade to Neutral with a CHF 165 target, as support for the updated view.
CLN
CHF 7.46
Clariant
7D
-0.9%
1Y
-13.3%
Narrative Update • Jun 23

CLN: Pricing Power And Specialty Focus Will Drive Re Rating Potential

Clariant's analyst price target has been revised lower by CHF 1.40 to reflect a recalibrated fair value, with analysts citing recent cuts to CHF 7.50 from Deutsche Bank and Citi, as well as more balanced views from Goldman Sachs at CHF 8.50 and JPMorgan at CHF 9.30, as they reassess the stock's quality profile, pricing power and valuation. Analyst Commentary Recent research on Clariant points to a mixed but increasingly constructive tone, with several bullish analysts highlighting improving quality perceptions and a more supportive view on valuation.
GURN
CHF 38.40
Gurit Holding
7D
11.3%
1Y
119.4%
Narrative Update • Jun 22

GURN: Steady Assumptions Will Likely Leave Shares Looking Overvalued

Analysts have kept their CHF fair value estimate for Gurit Holding steady at CHF 23.21, with minor tweaks to inputs such as the discount rate and future P/E assumptions. Together, these adjustments leave the overall price target effectively unchanged.
EMSN
CHF 711.50
EMS-CHEMIE HOLDING
7D
1.6%
1Y
20.3%